학술논문

Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial
Document Type
Article
Source
In The Lancet 15-21 August 2015 386(9994):665-671
Subject
Primary Research
Articles
Language
ISSN
0140-6736